HEPATITIS B-IG Behring 1000 UI ser pré 5 ml
7680006740044
CH-674
J06BB04
08.09.
1 / 2
google
Details
- Product number
- 0067401
- CPT
- -
- Packaging group
- 5
- Unit
- ml
- Composition
- immunoglobulinum humanum hepatitidis B min. 200 U.I. corresp. immunoglobulinum humanum normale min. 95 % corresp. proteina 100-170 mg, glycinum, natrii chloridum corresp. natrium max. 1.18 mg, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Hepatitis-B-Immunglobulin Behring, Injektionslösung
Injektionslösung
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
- | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
CSL Behring AG
3014 Bern
Authorization information
- Swissmedic authorization number
- 674
- Drug name
- Hepatitis-B-Immunglobulin Behring, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- J06BB04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 01/03/2004
- Authorization expiration date
- 31/12/9999
- IT number
- 08.09.
- Domain
- Human medicine
Packaging details
- Description (FR)
- HEPATITIS B-IG Behring 1000 UI ser pré 5 ml
- Description (DE)
- HEPATITIS B-IG Behring 1000 IE Fertspr 5 ml
- Market launch
- 01/03/2004
- Narcotic (BTM)
- No
Application methods
IMU